Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
Titel:
Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial
Auteur:
Kim, Dong-Wan Mehra, Ranee Tan, Daniel S W Felip, Enriqueta Chow, Laura Q M Camidge, D Ross Vansteenkiste, Johan Sharma, Sunil De Pas, Tommaso Riely, Gregory J Solomon, Benjamin J Wolf, Jürgen Thomas, Michael Schuler, Martin Liu, Geoffrey Santoro, Armando Sutradhar, Santosh Li, Siyu Szczudlo, Tomasz Yovine, Alejandro Shaw, Alice T